THIS PAGE IS TEMPORARILY UNDER CONSTRUCTION WHILE ENHANCEMENTS ARE UNDERWAY. Drug shortage data continues to be updated while under construction.
Current and Resolved Drug Shortages and Discontinuations Reported to FDA
Report a Drug Shortage |
Contact Us |
FAQ |
Background Info |
Get Email Alerts |
Download Current Drug Shortages
Start Over | Back to Previous Screen
Bupivacaine Hydrochloride Injection
Status: Currently in Shortage
»Date first posted:
02/20/2018
»Therapeutic Categories: Anesthesia
Areva Pharmaceuticals, Inc. (Revised 05/04/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 59923-717-05) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 59923-719-10) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 59923-718-05) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 59923-720-10) | Available | Demand increase for the drug |
Eugia Pharma Specialties LTD. (Revised 09/07/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Bupivacaine Hydrochloride Preservative Free, Injection, 2.5 mg/1 mL (NDC 55150-167-10) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride Preservative Free, Injection, 2.5 mg/1 mL (NDC 55150-168-30) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride Preservative Free, Injection, 5 mg/1 mL (NDC 55150-169-10) | Currently on backorder - next shipment September 2023 | Check wholesalers for inventory | Demand increase for the drug |
| Bupivacaine Hydrochloride Preservative Free, Injection, 5 mg/1 mL (NDC 55150-170-30) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride Preservative Free, Injection, 7.5 mg/1 mL (NDC 55150-171-10) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride Preservative Free, Injection, 7.5 mg/1 mL (NDC 55150-172-30) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 55150-249-50) | Available | Demand increase for the drug | |
| Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 55150-250-50) | Currently on backorder - next shipment TBD | Check wholesalers for inventory | Demand increase for the drug |
Fresenius Kabi USA, LLC (Revised 09/01/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-465-57) | Backordered. Next release June 2023. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-467-57) | Backordered. Next release September 2023. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-17) | Next release not available at this time. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-37) | Next release not available at this time. | Demand increase for the drug | |
| Sensorcaine, Injection, 2.5 mg/1 mL (NDC 63323-464-31) | Backordered. Next release date not available at this time. | Demand increase for the drug | |
| Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-17) | Backordered. Next release not available at this time. | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-37) | Next release not available at this time. | Demand increase for the drug | |
| Sensorcaine, Injection, 5 mg/1 mL (NDC 63323-466-31) | Backordered. Next release not available at this time. | Demand increase for the drug | |
| Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-17) | Available | Check wholesalers for inventory. | Demand increase for the drug |
| Sensorcaine, Injection, 7.5 mg/1 mL (NDC 63323-472-37) | Available | Check wholesalers for inventory. | Demand increase for the drug |
Hospira, Inc. (Revised 09/11/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-1159-01) | Next Delivery: September 2023; Estimated Recovery: December 2023 |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-1159-02) | Limited Supply Available. Next Delivery: September 2023; Estimated Recovery: March 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 0409-1160-01) | Next Delivery: March 2024; Estimated Recovery: December 2024 |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 0409-1162-01) | Next Delivery: September 2023; Estimated Recovery: December 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 0409-1162-02) | Next Delivery: October 2023; Estimated Recovery: March 2024 |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 0409-1163-01) | Next Delivery: January 2024; Estimated Recovery: June 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-01) | Limited Supply Available. Next Delivery: October 2023; Estimated Recovery: December 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-1165-02) | Available |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 0409-3613-01) | Depleted |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Marcaine, Injection, 2.5 mg/1 mL (NDC 0409-1559-10) | Next Delivery: October 2023; Estimated Recovery: December 2023 |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Marcaine, Injection, 2.5 mg/1 mL (NDC 0409-1559-30) | Limited Supply Available. Next Delivery: October 2023; Estimated Recovery: December 2023 |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Marcaine, Injection, 2.5 mg/1 mL (NDC 0409-1587-50) | Available |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Marcaine, Injection, 5 mg/1 mL (NDC 0409-1560-10) | Next Delivery: November 2023; Estimated Recovery: March 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Marcaine, Injection, 5 mg/1 mL (NDC 0409-1560-29) | Limited Supply Available. Next Delivery: January 2024; Estimated Recovery: June 2024 |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Marcaine, Injection, 5 mg/1 mL (NDC 0409-1610-50) | Limited Supply Available. Next Delivery: September 2023; Estimated Recovery: June 2024 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Marcaine, Injection, 7.5 mg/1 mL (NDC 0409-1582-10) | Limited Supply Available. Next Delivery and Estimated Recovery: September 2023 | Check Wholesaler for Availability Shortage per Manufacturer: Manufacturing Delay
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
| Marcaine, Injection, 7.5 mg/1 mL (NDC 0409-1582-29) | Available |
Dear Customer Letter - Supply Update of Earlier Delivery Dates |
Demand increase for the drug |
Huons Co., Ltd (Revised 11/15/2022)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Bupivacaine Hydrochloride, Injection, 7.5 mg/1 mL (NDC 73293-0002-2) | Available |
Kindos Pharmaceuticals Co. Ltd. (Revised 07/28/2023)
| Presentation | Availability and Estimated Shortage Duration | Related Information | Shortage Reason (per FDASIA) |
|---|---|---|---|
| Bupivacaine Hydrochloride, Injection, 2.5 mg/1 mL (NDC 71288-723-52) | Available | Meitheal Pharmaceuticals is distributor/labeler | Demand increase for the drug |
| Bupivacaine Hydrochloride, Injection, 5 mg/1 mL (NDC 71288-726-52) | Available | Meitheal Pharmaceuticals is distributor/labeler | Demand increase for the drug |